Literature DB >> 35237497

Treatment of Central Vertigo With Low Dose Olanzapine: Report of Two Cases.

Connie Jiang1, Anusha Lekshminarayanan2, Ihsan Balkaya2, Alal Uddin2, Sheital Bavishi3, Eric Altschuler2.   

Abstract

Good treatments are available for many cases of vertigo due to a peripheral cause such as benign paroxysmal positional vertigo. Conversely, vertigo secondary to a central lesion remains a treatment challenge typically without good pharmacologic or other treatments. We have successfully treated two patients, the first to our knowledge, with central vertigo, one from brain injury, one after stroke, with low dose olanzapine which we found to quickly and dramatically resolve vertigo and permit functional normalization. In our two cases, we found that a low dose of olanzapine 2.5mg daily (typical dosing of olanzapine for the psychiatric disease is 5-20mg daily) caused vertigo to rapidly and dramatically remit. Interestingly, our two cases had different causes and possibly lesion locations.
Copyright © 2022, Jiang et al.

Entities:  

Keywords:  central; olanzapine; peripheral; treatment; vertigo

Year:  2022        PMID: 35237497      PMCID: PMC8882308          DOI: 10.7759/cureus.22647

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

Review 1.  The treatment and natural course of peripheral and central vertigo.

Authors:  Michael Strupp; Marianne Dieterich; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2013-07-22       Impact factor: 5.594

Review 2.  Olanzapine.

Authors:  A S Hale
Journal:  Br J Hosp Med       Date:  1997 Nov 5-18

Review 3.  Clinical practice. Benign paroxysmal positional vertigo.

Authors:  Ji-Soo Kim; David S Zee
Journal:  N Engl J Med       Date:  2014-03-20       Impact factor: 91.245

Review 4.  Weight gain and antipsychotics: a drug safety review.

Authors:  Richard Musil; Michael Obermeier; Paul Russ; Michael Hamerle
Journal:  Expert Opin Drug Saf       Date:  2014-11-15       Impact factor: 4.250

5.  [Repositioning maneuver in benign paroxysmal vertigo of horizontal semicircular canal].

Authors:  M Gufoni; L Mastrosimone; F Di Nasso
Journal:  Acta Otorhinolaryngol Ital       Date:  1998-12       Impact factor: 2.124

Review 6.  Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes.

Authors:  Mehmet Karatas
Journal:  Neurologist       Date:  2008-11       Impact factor: 1.398

Review 7.  Clinical Evaluation of Patients with Vestibular Dysfunction.

Authors:  Vijay Renga
Journal:  Neurol Res Int       Date:  2019-02-03

Review 8.  Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.

Authors:  Anna Sutherland; Katrien Naessens; Emma Plugge; Lynda Ware; Karen Head; Martin J Burton; Bee Wee
Journal:  Cochrane Database Syst Rev       Date:  2018-09-21

9.  Olanzapine and Betamethasone Are Effective for the Treatment of Nausea and Vomiting due to Metastatic Brain Tumors of Rectal Cancer.

Authors:  M Suzuki; K Komuro; K Ohara
Journal:  Case Rep Gastroenterol       Date:  2014-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.